Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications.

Craft S.

Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):298-301. Review.

PMID:
17132977
2.
3.
4.

Insulin resistance and Alzheimer's disease: molecular links & clinical implications.

Neumann KF, Rojo L, Navarrete LP, Farías G, Reyes P, Maccioni RB.

Curr Alzheimer Res. 2008 Oct;5(5):438-47.

PMID:
18855585
5.

Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.

Watson GS, Craft S.

J Neurol Sci. 2006 Jun 15;245(1-2):21-33. Epub 2006 Apr 24. Review.

PMID:
16631207
6.
7.

Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

Biessels GJ, Kappelle LJ; Utrecht Diabetic Encephalopathy Study Group..

Biochem Soc Trans. 2005 Nov;33(Pt 5):1041-4. Review.

PMID:
16246041
8.
9.

Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.

Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S, Mohanty P.

Curr Mol Med. 2008 Dec;8(8):816-28. Review.

PMID:
19075678
10.

The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals.

Reaven G.

Endocrinol Metab Clin North Am. 2004 Jun;33(2):283-303. Review.

PMID:
15158520
12.

Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'?

Greenfield JR, Campbell LV.

Curr Diabetes Rev. 2006 May;2(2):195-211. Review.

PMID:
18220627
13.

Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients.

Forst T, Hohberg C, Pfützner A.

Horm Metab Res. 2009 Feb;41(2):123-31. doi: 10.1055/s-0028-1119378. Epub 2009 Feb 12. Review.

PMID:
19214922
14.

Hypertension in people with diabetes and the metabolic syndrome: pathophysiologic insights and therapeutic update.

Ganne S, Arora SK, Dotsenko O, McFarlane SI, Whaley-Connell A.

Curr Diab Rep. 2007 Jun;7(3):208-17. Review.

PMID:
17547838
15.

Treatment of hypertension in metabolic syndrome: implications of recent clinical trials.

Makaryus AN, Akhrass P, McFarlane SI.

Curr Diab Rep. 2009 Jun;9(3):229-37. Review.

PMID:
19490825
16.

Insulin resistance and the metabolic syndrome--or the pitfalls of epidemiology.

Yudkin JS.

Diabetologia. 2007 Aug;50(8):1576-86. Epub 2007 Jun 26. Review.

PMID:
17593345
17.

Albuminuria and chronic kidney disease in association with the metabolic syndrome.

Ninomiya T, Kiyohara Y.

J Cardiometab Syndr. 2007 Spring;2(2):104-7. Review.

18.

Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.

Resmini E, Minuto F, Colao A, Ferone D.

Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26. Review.

PMID:
19322513
19.

Metabolic syndrome and NASH.

Marchesini G, Marzocchi R.

Clin Liver Dis. 2007 Feb;11(1):105-17, ix. Review.

PMID:
17544974
20.

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, Mehta P, Craft S.

Neurology. 2008 Feb 5;70(6):440-8. Epub 2007 Oct 17. Erratum in: Neurology. 2008 Sep 9;71(11):866.

PMID:
17942819

Supplemental Content

Support Center